Dimensional Fund Advisors LP raised its stake in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) by 2.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,332,445 shares of the company's stock after acquiring an additional 47,265 shares during the period. Dimensional Fund Advisors LP owned about 0.70% of Kimberly-Clark worth $331,703,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of KMB. Elevate Capital Advisors LLC boosted its holdings in shares of Kimberly-Clark by 46.4% in the 1st quarter. Elevate Capital Advisors LLC now owns 12,444 shares of the company's stock worth $1,770,000 after buying an additional 3,944 shares during the last quarter. Citigroup Inc. raised its stake in Kimberly-Clark by 86.8% in the 1st quarter. Citigroup Inc. now owns 509,585 shares of the company's stock valued at $72,473,000 after acquiring an additional 236,733 shares during the period. Unigestion Holding SA lifted its stake in shares of Kimberly-Clark by 8.2% during the 1st quarter. Unigestion Holding SA now owns 127,623 shares of the company's stock valued at $18,145,000 after buying an additional 9,643 shares in the last quarter. OVERSEA CHINESE BANKING Corp Ltd boosted its holdings in Kimberly-Clark by 270.2% in the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 984,695 shares of the company's stock worth $140,043,000 after buying an additional 718,720 shares during the period. Finally, Farmers Trust Co. grew its position in shares of Kimberly-Clark by 108.6% in the first quarter. Farmers Trust Co. now owns 45,088 shares of the company's stock valued at $6,412,000 after purchasing an additional 23,472 shares in the last quarter. 76.29% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on KMB. UBS Group decreased their target price on shares of Kimberly-Clark from $146.00 to $139.00 and set a "neutral" rating on the stock in a report on Thursday, July 17th. Piper Sandler started coverage on shares of Kimberly-Clark in a research report on Friday, July 18th. They set an "overweight" rating and a $144.00 target price for the company. Wall Street Zen lowered shares of Kimberly-Clark from a "buy" rating to a "hold" rating in a report on Thursday, April 24th. JPMorgan Chase & Co. raised shares of Kimberly-Clark from an "underweight" rating to a "neutral" rating and lifted their price objective for the stock from $125.00 to $138.00 in a report on Monday, August 4th. Finally, Barclays lifted their price target on Kimberly-Clark from $134.00 to $139.00 and gave the stock an "equal weight" rating in a research note on Monday, August 4th. Three research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Kimberly-Clark has an average rating of "Hold" and an average price target of $142.70.
View Our Latest Research Report on Kimberly-Clark
Kimberly-Clark Stock Up 0.7%
KMB stock traded up $0.92 during midday trading on Friday, hitting $133.89. The stock had a trading volume of 601,006 shares, compared to its average volume of 2,312,236. The business has a 50-day moving average of $130.38 and a two-hundred day moving average of $135.11. The company has a debt-to-equity ratio of 7.05, a current ratio of 0.80 and a quick ratio of 0.54. The firm has a market cap of $44.42 billion, a price-to-earnings ratio of 17.72, a price-to-earnings-growth ratio of 4.46 and a beta of 0.33. Kimberly-Clark Co. has a 52-week low of $124.10 and a 52-week high of $150.45.
Kimberly-Clark (NYSE:KMB - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $1.92 earnings per share for the quarter, beating analysts' consensus estimates of $1.67 by $0.25. Kimberly-Clark had a return on equity of 201.43% and a net margin of 12.69%.The company had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.85 billion. During the same quarter last year, the company earned $1.96 EPS. The firm's revenue for the quarter was down 1.6% on a year-over-year basis. As a group, equities research analysts forecast that Kimberly-Clark Co. will post 7.5 earnings per share for the current fiscal year.
Kimberly-Clark Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 2nd. Shareholders of record on Friday, September 5th will be given a $1.26 dividend. The ex-dividend date is Friday, September 5th. This represents a $5.04 annualized dividend and a yield of 3.8%. Kimberly-Clark's dividend payout ratio (DPR) is presently 69.42%.
Kimberly-Clark Profile
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Read More

Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.